Evidence map›Paper›PMID 37486304›Full record

ArticleJournal of chemical information and modeling2023

Mechanism of Ligand Discrimination by the

Amit Kumar, Harish Vashisth

Open access · greenAbstract read
In one paragraph

Article in Journal of chemical information and modeling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amit KumarDepartment of Chemical Engineering, University of New Hampshire, Durham, New Hampshire 03824, United States.
Harish VashisthDepartment of Chemical Engineering, University of New Hampshire, Durham, New Hampshire 03824, United States.ORCID 0000-0002-2087-2880
University of New Hampshire · US

Funding

Peptides and Small-molecules Targeting Signaling Proteins and Protein-Protein InterfacesR35GM138217 · NIGMS · UNIVERSITY OF NEW HAMPSHIRE · PI Harish Vashisth · 2020 to 2026
$2.9M
NIGMS NIH HHS R35 GM138217
6 · The paper itself

Abstract

Riboswitches are conserved functional domains in mRNA that almost exclusively exist in bacteria. They regulate the biosynthesis and transport of amino acids and essential metabolites such as coenzymes, nucleobases, and their derivatives by specifically binding small molecules. Due to their ability to precisely discriminate between different cognate molecules as well as their common existence in bacteria, riboswitches have become potential antibacterial drug targets that could deliver urgently needed antibiotics with novel mechanisms of action. In this work, we report the recognition mechanisms of four oxidization products (XAN, AZA, UAC, and HPA) generated during purine degradation by an RNA motif termed the

Indexed as

RiboswitchBacteriaLigandsNucleic Acid ConformationLigandsRiboswitch

Identifiers

PMID37486304
PMCPMC11088486
OpenAlexW4385186126

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.